Yu J (2006) CST Curation Set: 2098; Year: 2006; Biosample/Treatment: tissue, larynx/-; Disease: laryngeal cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine Mouse mAb (P-Tyr-100) Cat#: 9411, PTMScan(R) Phospho-Tyr Motif (Y*) Immunoaffinity Beads Cat#: 1991

This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.

Click on the protein name to open the protein page, and on the RSD number to open the site page.

Download

Y628-p - ADD1 iso2 (human) ▲
Modsite: GDGCAREyLLP____ SwissProt Entrez-Gene Orthologous residues ADD1 (human): ‑, ADD1 iso2 (human): Y628‑p, ADD1 iso3 (human): ‑, ADD1 iso4 (human): Y659‑p, ADD1 iso6 (human): Y659‑p, ADD1 (mouse): ‑, ADD1 iso2 (mouse): Y629‑p, ADD1 iso3 (mouse): ‑, ADD1 (rat): ‑, ADD1 (cow): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry

Y496-p - ALOX12B (human) ▲
Modsite: GVQDLPGyyYRDDSL SwissProt Entrez-Gene Orthologous residues ALOX12B (human): Y496‑p, ALOX12B (mouse): Y496‑p, ALOX12B (rat): Y496‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y497-p - ALOX12B (human) ▲
Modsite: VQDLPGyyYRDDSLA SwissProt Entrez-Gene Orthologous residues ALOX12B (human): Y497‑p, ALOX12B (mouse): Y497‑p, ALOX12B (rat): Y497‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y340-p - B4GALT6 (human) ▲
Modsite: GRYKLLRySKERQyI SwissProt Entrez-Gene Orthologous residues B4GALT6 (human): Y340‑p, B4GALT6 (mouse): Y340‑p, B4GALT6 (rat): Y340‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y346-p - B4GALT6 (human) ▲
Modsite: RySKERQyIDGLNNL SwissProt Entrez-Gene Orthologous residues B4GALT6 (human): Y346‑p, B4GALT6 (mouse): Y346‑p, B4GALT6 (rat): F346‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y355-p - B4GALT6 (human) ▲
Modsite: DGLNNLIyRPKILVD SwissProt Entrez-Gene Orthologous residues B4GALT6 (human): Y355‑p, B4GALT6 (mouse): Y355‑p, B4GALT6 (rat): Y355‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y970-p - BTBD11 (human) ▲
Modsite: IEIGYVKySIFQLVM SwissProt Entrez-Gene Orthologous residues BTBD11 (human): Y970‑p, BTBD11 (mouse): Y975‑p, BTBD11 iso4 (mouse): Y506‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y981-p - BTBD11 (human) ▲
Modsite: QLVMQYLyyGGPEsL SwissProt Entrez-Gene Orthologous residues BTBD11 (human): Y981‑p, BTBD11 (mouse): Y986‑p, BTBD11 iso4 (mouse): Y517‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y982-p - BTBD11 (human) ▲
Modsite: LVMQYLyyGGPEsLL SwissProt Entrez-Gene Orthologous residues BTBD11 (human): Y982‑p, BTBD11 (mouse): Y987‑p, BTBD11 iso4 (mouse): Y518‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y1181-p - C2CD3 (human) ▲
Modsite: LLDVGLRyRRsPRtA SwissProt Entrez-Gene Orthologous residues C2CD3 (human): Y1181‑p, C2CD3 (mouse): Y1165‑p, C2CD3 (rat): Y1161‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y498-p - CAPN14 (human) ▲
Modsite: FSRKHIFyEIGSNSG SwissProt Entrez-Gene Orthologous residues CAPN14 (human): Y498‑p, CAPN14 iso2 (human): Y322‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y707-p - CDCP1 (human) ▲
Modsite: kGPAVGIyNDNINTE SwissProt Entrez-Gene Orthologous residues CDCP1 (human): Y707‑p, CDCP1 (mouse): Y705‑p, CDCP1 (rat): Y705‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y172-p - CDHR3 (human) ▲
Modsite: SRNIPLSyFLISPPK SwissProt Entrez-Gene Orthologous residues CDHR3 (human): Y172‑p, CDHR3 (mouse): Y172‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y15-p - CDK1 (human) ▲
Modsite: EkIGEGtyGVVykGR SwissProt Entrez-Gene Orthologous residues CDK1 (human): Y15‑p, CDK1 iso2 (human): Y15‑p, CDK1 (mouse): Y15‑p, CDK1 (rat): Y15‑p, CDK1 (chicken): Y15‑p, CDK1 (fruit fly): Y15‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y15-p - CDK2 (human) ▲
Modsite: EkIGEGtyGVVykAR SwissProt Entrez-Gene Orthologous residues CDK2 (human): Y15‑p, CDK2 iso2 (human): Y15‑p, CDK2 (mouse): Y15‑p, CDK2 (rat): Y15‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y15-p - CDK3 (human) ▲
Modsite: EkIGEGtyGVVyKAK SwissProt Entrez-Gene Orthologous residues CDK3 (human): Y15‑p, CDK3 (mouse): Y15‑p, CDK3 (cow): Y15‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y168-p - CFAP36 (human) ▲
Modsite: LRKSKEEyDQEEERK SwissProt Entrez-Gene Orthologous residues CFAP36 (human): Y168‑p, CFAP36 iso2 (human): Y193‑p, CFAP36 (mouse): Y168‑p, CFAP36 (rat): Y168‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y253-p - CIP2A (human) ▲
Modsite: DGtLtRKySVDLLMD SwissProt Entrez-Gene Orthologous residues CIP2A (human): Y253‑p, CIP2A (mouse): Y255‑p, CIP2A (rat): Y255‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y174-p - CKM (human) ▲
Modsite: GEFkGKyyPLKsMtE SwissProt Entrez-Gene Orthologous residues CKM (human): Y174‑p, CKM (mouse): Y174‑p, CKM (rat): Y174‑p, CKM (chicken): Y174‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y60-p - CTH (human) ▲
Modsite: GQHsGFEySRSGNPT SwissProt Entrez-Gene Orthologous residues CTH (human): Y60‑p, CTH (mouse): Y59‑p, CTH (rat): Y59‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y228-p - CTNND1 (human) ▲

Modsite: yPGGsDNyGsLsRVt SwissProt Entrez-Gene Orthologous residues CTNND1 (human): Y228‑p, CTNND1 iso2 (human): Y228‑p, CTNND1 iso3 (human): Y228‑p, CTNND1 iso4 (human): Y228‑p, CTNND1 iso10 (human): Y174‑p, CTNND1 iso12 (human): Y174‑p, CTNND1 iso22 (human): Y127‑p, CTNND1 (mouse): Y228‑p, CTNND1 iso2 (mouse): Y228‑p, CTNND1 iso3 (mouse): Y228‑p, CTNND1 (rat): Y228‑p, CTNND1 (cow): Y228‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y792-p - DDR1 (human) ▲
Modsite: FGMsRNLyAGDyyRV SwissProt Entrez-Gene Orthologous residues DDR1 (human): Y792‑p, DDR1 iso2 (human): Y755‑p, DDR1 iso5 (human): Y798‑p, DDR1 (mouse): Y790‑p, DDR1 (rat): Y789‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y796-p - DDR1 (human) ▲
Modsite: RNLyAGDyyRVQGRA SwissProt Entrez-Gene Orthologous residues DDR1 (human): Y796‑p, DDR1 iso2 (human): Y759‑p, DDR1 iso5 (human): Y802‑p, DDR1 (mouse): Y794‑p, DDR1 (rat): Y793‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y343-p - dematin (human) ▲
Modsite: CVLEQKIyPYEMLVV SwissProt Entrez-Gene Orthologous residues dematin (human): Y343‑p, dematin iso2 (human): Y321‑p, dematin (mouse): Y343‑p, dematin iso2 (mouse): Y321‑p, dematin (rat): Y343‑p, dematin iso2 (rat): Y321‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y721-p - DNAPK (human) ▲
Modsite: VAVkMKQyKDELLAS SwissProt Entrez-Gene Orthologous residues DNAPK (human): Y721‑p, DNAPK iso2 (human): Y721‑p, DNAPK (mouse): Y720‑p, DNAPK (rat): Y720‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y321-p - DYRK1A (human) ▲
Modsite: LGQRIyQyIQsRFYR SwissProt Entrez-Gene Orthologous residues DYRK1A (human): Y321‑p, DYRK1A iso2 (human): Y312‑p, DYRK1A iso4 (human): Y321‑p, DYRK1A (mouse): Y321‑p, DYRK1A (rat): Y321‑p, DYRK1A (rabbit): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry

Y273-p - DYRK1B (human) ▲
Modsite: LGQRIyQyIQsRFYR SwissProt Entrez-Gene Orthologous residues DYRK1B (human): Y273‑p, DYRK1B iso2 (human): Y273‑p, DYRK1B (mouse): Y273‑p, DYRK1B (rat): Y273‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y383-p - enamelin (human) ▲
Modsite: NPVYHKAyPPTSRGN SwissProt Entrez-Gene Orthologous residues enamelin (human): Y383‑p, enamelin (mouse): P383‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y204-p - ERK1 (human) ▲
Modsite: HtGFLtEyVAtRWyr SwissProt Entrez-Gene Orthologous residues ERK1 (human): Y204‑p, ERK1 iso2 (human): Y204‑p, ERK1 iso3 (human): Y204‑p, ERK1 (mouse): Y205‑p, ERK1 (rat): Y205‑p, ERK1 (hamster): Y194‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y187-p - ERK2 (human) ▲
Modsite: HtGFLtEyVAtRWyr SwissProt Entrez-Gene Orthologous residues ERK2 (human): Y187‑p, ERK2 (mouse): Y185‑p, ERK2 (rat): Y185‑p, ERK2 (chicken): Y195‑p, ERK2 (cow): Y187‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y458-p - FANCD2 (human) ▲
Modsite: ISFGSLLyKYAFKFF SwissProt Entrez-Gene Orthologous residues FANCD2 (human): Y458‑p, FANCD2 iso1 (human): Y458‑p, FANCD2 iso3 (human): Y458‑p, FANCD2 (mouse): Y456‑p, FANCD2 (rat): C458‑p, FANCD2 (chicken): Y461‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y394-p - FASTKD2 (human) ▲
Modsite: QsCKDLQyHNLDLFK SwissProt Entrez-Gene Orthologous residues FASTKD2 (human): Y394‑p, FASTKD2 (mouse): Y380‑p, FASTKD2 (rat): Y370‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y406-p - FASTKD2 (human) ▲
Modsite: LFKGLADyVAATFDI SwissProt Entrez-Gene Orthologous residues FASTKD2 (human): Y406‑p, FASTKD2 (mouse): Y392‑p, FASTKD2 (rat): Y382‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y191-p - FNDC4 (human) ▲
Modsite: IGLFCRQyDIIKDND SwissProt Entrez-Gene Orthologous residues FNDC4 (human): Y191‑p, FNDC4 (mouse): Y187‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y318-p - FRMPD1 (human) ▲
Modsite: LHIQERIyACAQPQK SwissProt Entrez-Gene Orthologous residues FRMPD1 (human): Y318‑p, FRMPD1 (mouse): Y318‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y196-p - GNMT (human) ▲
Modsite: APPGKNIyyKsDLTK SwissProt Entrez-Gene Orthologous residues GNMT (human): Y196‑p, GNMT (mouse): Y194‑p, GNMT (rat): Y194‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y197-p - GNMT (human) ▲
Modsite: PPGKNIyyKsDLTKD SwissProt Entrez-Gene Orthologous residues GNMT (human): Y197‑p, GNMT (mouse): Y195‑p, GNMT (rat): Y195‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y1105-p - GRF-1 (human) ▲
Modsite: RNEEENIysVPHDst SwissProt Entrez-Gene Orthologous residues GRF‑1 (human): Y1105‑p, GRF‑1 (mouse): Y1105‑p, GRF‑1 (rat): Y1105‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y279-p - GSK3A (human) ▲
Modsite: RGEPNVsyICsRyyR SwissProt Entrez-Gene Orthologous residues GSK3A (human): Y279‑p, GSK3A (mouse): Y279‑p, GSK3A (rat): Y279‑p, GSK3A (cow): Y279‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y216-p - GSK3B (human) ▲
Modsite: RGEPNVsyICsRyyR SwissProt Entrez-Gene Orthologous residues GSK3B (human): Y216‑p, GSK3B iso2 (human): Y216‑p, GSK3B (mouse): Y216‑p, GSK3B (rat): Y216‑p, GSK3B (rabbit): Y216‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y41-p - H2B1A (human) ▲
Modsite: RKESYSIyIYKVLkQ SwissProt Entrez-Gene Orthologous residues H2B1A (human): Y41‑p, H2B1A (mouse): Y41‑p, H2B1A (rat): Y41‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y25-p - HBA1 (human) ▲
Modsite: VGAHAGEyGAEALER SwissProt Entrez-Gene Orthologous residues HBA1 (human): Y25‑p, HBA1 (mouse): Y25‑p, HBA1 (rat): Y25‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y209-p - Hck (human) ▲
Modsite: tLDNGGFyISPRSTF SwissProt Entrez-Gene Orthologous residues Hck (human): Y209‑p, Hck iso2 (human): Y188‑p, Hck iso3 (human): Y187‑p, Hck iso4 (human): Y208‑p, Hck (mouse): Y207‑p, Hck (rat): Y207‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y258-p - K5 (human) ▲
Modsite: VEDFKNkyEDEINkR SwissProt Entrez-Gene Orthologous residues K5 (human): Y258‑p, K5 (mouse): Y252‑p, K5 (rat): Y254‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y1605-p - KIF1A (human) ▲
Modsite: VVRRPYAyMyNSDKD SwissProt Entrez-Gene Orthologous residues KIF1A (human): Y1605‑p, KIF1A iso2 (human): Y1714‑p, KIF1A iso3 (human): Y1706‑p, KIF1A (mouse): Y1610‑p, KIF1A iso3 (mouse): Y1613‑p, KIF1A (rat): Y1622‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y1607-p - KIF1A (human) ▲
Modsite: RRPYAyMyNSDKDTV SwissProt Entrez-Gene Orthologous residues KIF1A (human): Y1607‑p, KIF1A iso2 (human): Y1716‑p, KIF1A iso3 (human): Y1708‑p, KIF1A (mouse): Y1612‑p, KIF1A iso3 (mouse): Y1615‑p, KIF1A (rat): Y1624‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y305-p - KLC4 (human) ▲
Modsite: LNNLAVLyGkRGKYK SwissProt Entrez-Gene Orthologous residues KLC4 (human): Y305‑p, KLC4 iso3 (human): Y323‑p, KLC4 (mouse): Y305‑p, KLC4 (rat): Y305‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y547-p - LTF (human) ▲
Modsite: sNERYyGytGAFRCL SwissProt Entrez-Gene Orthologous residues LTF (human): Y547‑p, LTF iso2 (human): Y503‑p, LTF (mouse): Y544‑p, LTF (rat): Y544‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y508-p - LYN (human) ▲
Modsite: ytAtEGQyQQQP___ SwissProt Entrez-Gene Orthologous residues LYN (human): Y508‑p, LYN iso2 (human): Y487‑p, LYN (mouse): Y508‑p, LYN iso2 (mouse): Y487‑p, LYN (rat): Y508‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y1076-p - MEKK4 (human) ▲
Modsite: FARKWMNyVLTKCES SwissProt Entrez-Gene Orthologous residues MEKK4 (human): Y1076‑p, MEKK4 iso2 (human): Y1076‑p, MEKK4 (mouse): Y1067‑p, MEKK4 iso2 (mouse): Y1067‑p, MEKK4 (rat): Y909‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y107-p - MTM1 (human) ▲
Modsite: TSRGENsyGLDItCk SwissProt Entrez-Gene Orthologous residues MTM1 (human): Y107‑p, MTM1 (mouse): Y107‑p, MTM1 (rat): Y107‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y673-p - MYO10 (human) ▲
Modsite: VRIRKAGyAVRRPFQ SwissProt Entrez-Gene Orthologous residues MYO10 (human): Y673‑p, MYO10 (mouse): Y673‑p, MYO10 (rat): Y673‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y407-p - NXF3 (human) ▲
Modsite: IKILKDPyLRGELLK SwissProt Entrez-Gene Orthologous residues NXF3 (human): Y407‑p, NXF3 (mouse): Y381‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y278-p - OR1Q1 (human) ▲
Modsite: GRIITVVyTVVTPML SwissProt Entrez-Gene Orthologous residues OR1Q1 (human): Y278‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y182-p - P38A (human) ▲
Modsite: tDDEMtGyVAtRWYR SwissProt Entrez-Gene Orthologous residues P38A (human): Y182‑p, P38A iso2 (human): Y182‑p, P38A (mouse): Y182‑p, P38A iso3 (mouse): Y182‑p, P38A (rat): Y182‑p, P38A (salmonid): Y183‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y172-p - PARP9 (human) ▲
Modsite: SkQFVARyGkVSAGE SwissProt Entrez-Gene Orthologous residues PARP9 (human): Y172‑p, PARP9 iso2 (human): Y137‑p, PARP9 (mouse): V174‑p, PARP9 iso2 (mouse): V138‑p, PARP9 (rat): H138‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y279-p - PCDHGA2 (human) ▲
Modsite: GYYAQVVyFLEKSPG SwissProt Entrez-Gene Orthologous residues PCDHGA2 (human): Y279‑p, PCDHGA2 (mouse): Y287‑p, PCDHGA2 (rat): Y279‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y196-p - PGK1 (human) ▲
Modsite: LMkkELNyFAkALEs SwissProt Entrez-Gene Orthologous residues PGK1 (human): Y196‑p, PGK1 (mouse): Y196‑p, PGK1 (rat): Y196‑p, PGK1 (cow): Y196‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y209-p - PIGM (human) ▲
Modsite: KSLRQFRyTFQACLY SwissProt Entrez-Gene Orthologous residues PIGM (human): Y209‑p, PIGM (mouse): F209‑p, PIGM (rat): Y209‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y313-p - PKCD (human) ▲
Modsite: ssEPVGIyQGFEKkT SwissProt Entrez-Gene Orthologous residues PKCD (human): Y313‑p, PKCD iso2 (human): Y313‑p, PKCD (mouse): Y311‑p, PKCD iso2 (mouse): Y311‑p, PKCD (rat): Y311‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y14-p - PTP4A3 (human) ▲
Modsite: PAPVEVsyKHMRFLI SwissProt Entrez-Gene Orthologous residues PTP4A3 (human): Y14‑p, PTP4A3 (mouse): Y14‑p, PTP4A3 (rat): Y14‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y221-p - SFXN5 (human) ▲
Modsite: CNVVLMRyGELEEGI SwissProt Entrez-Gene Orthologous residues SFXN5 (human): Y221‑p, SFXN5 (mouse): Y223‑p, SFXN5 (rat): Y223‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y176-p - SLC25A32 (human) ▲
Modsite: TLVKIYkyEGVRGLY SwissProt Entrez-Gene Orthologous residues SLC25A32 (human): Y176‑p, SLC25A32 (mouse): Y176‑p, SLC25A32 (rat): Y176‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y203-p - SLC25A32 (human) ▲
Modsite: GALQFMAyELLKLkY SwissProt Entrez-Gene Orthologous residues SLC25A32 (human): Y203‑p, SLC25A32 (mouse): Y203‑p, SLC25A32 (rat): Y203‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y18-p - SLC6A13 (human) ▲
Modsite: NGETKPVyPVMEKKE SwissProt Entrez-Gene Orthologous residues SLC6A13 (human): Y18‑p, SLC6A13 (mouse): C18‑p, SLC6A13 (rat): C18‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y51-p - SNX17 (human) ▲
Modsite: HEQLRKEyGANVLPA SwissProt Entrez-Gene Orthologous residues SNX17 (human): Y51‑p, SNX17 (mouse): Y51‑p, SNX17 (rat): Y51‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y530-p - Src (human) ▲
Modsite: FTstEPQyQPGENL_ SwissProt Entrez-Gene Orthologous residues Src (human): Y530‑p, Src iso2 (human): Y536‑p, Src (mouse): Y529‑p, Src iso1 (mouse): Y535‑p, Src (rat): Y530‑p, Src (chicken): Y527‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y536-p - TF (human) ▲
Modsite: NKEGyyGytGAFRCL SwissProt Entrez-Gene Orthologous residues TF (human): Y536‑p, TF (mouse): Y537‑p, TF (rat): Y536‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y61-p - Vimentin (human) ▲
Modsite: AssPGGVyAtrssAV SwissProt Entrez-Gene Orthologous residues Vimentin (human): Y61‑p, Vimentin (mouse): Y61‑p, Vimentin (rat): Y61‑p, Vimentin (rabbit): Y61‑p, Vimentin (hamster): Y60‑p, Vimentin (cow): Y61‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y258-p - Wee1 (human) ▲
Modsite: CRRRKRTyWNDsCGE SwissProt Entrez-Gene Orthologous residues Wee1 (human): Y258‑p, Wee1 (mouse): Y258‑p, Wee1 (rat): Y258‑p, Wee1 (frog): R168‑p Characterization Methods used to characterize site in vivo:  mass spectrometry

Y272-p - Wee1 (human) ▲
Modsite: EDMEAsDyELEDETR SwissProt Entrez-Gene Orthologous residues Wee1 (human): Y272‑p, Wee1 (mouse): Y271‑p, Wee1 (rat): Y271‑p, Wee1 (frog): ‑ Characterization Methods used to characterize site in vivo:  mass spectrometry

Y170-p - ZCCHC24 (human) ▲
Modsite: KKRCFGEyKCPKCKR SwissProt Entrez-Gene Orthologous residues ZCCHC24 (human): Y170‑p, ZCCHC24 (mouse): Y170‑p, ZCCHC24 (rat): Y170‑p Characterization Methods used to characterize site in vivo:  mass spectrometry